SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 154(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report: October 13, 2000
MENTOR CORPORATION
(Exact Name of Registrants as Specified in Its Charter)
Commission File No. 0-7955
Mentor Corporation
201 Mentor Drive
Santa Barbara, California 93111
Telephone: 805/879-6000
A Minnesota Corporation I.R.S. Employer Identification
No. 41-0950791
On September 28, 2000 Mentor Corporation (NASDAQ: MNTR) announced
the resignation of Mr. Anthony R. Gette as the President, Chief
Executive Officer and Director of Mentor Corporation effective
immediately.
Mr. Christopher J. Conway, Chairman of the Board and Director,
was appointed President and Chief Executive Officer of the
corporation with immediate effect.
The resignation of Mr. Gette was for personal reasons.
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Amendment to be signed
on its behalf by the undersigned hereto duly authorized.
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, Mentor Corporation has duly
caused this Report to be signed on its behalf by the undersigned,
thereunto duly authorized.
MENTOR CORPORATION
Date: October 12, 2000 /s/CHRISTOPHER J. CONWAY
Christopher J. Conway, Chairman
Chief Executive Officer and President
Date: October 12, 2000 /s/ADEL MICHAEL
Senior Vice President
Chief Financial Officer
Mentor Chairman Resumes CEO Position
SANTA BARBARA, California, September 28, 2000 - Mentor
Corporation (NASDAQ: MNTR) today announced that its Chairman of
the Board, Christopher J. Conway, has resumed the position of
President and Chief Executive Officer following the resignation
of Anthony Gette as an officer and director of the Company.
Conway had been CEO of Mentor since the Company was founded in
1969 until July 1999, at which time Gette was appointed President
and CEO, after serving as Chief Operating Officer since 1987.
"Mr. Gette has decided to leave Mentor for personal reasons,"
Conway said. "We are very sorry to see him go; he has contributed
enormously to Mentor's success over the years, and we have
enjoyed working with him. We shall all miss him."
"I value the years I have worked with the people at Mentor to
build this fine Company," said Gette. "I will continue to be
available to work and consult with the Company during a
transition period over the next twelve months. Mentor has some
great products in growing markets, as well as a talented
management group, and I am confident the Company will continue to
grow and prosper."
Conway added comments about the Company's outlook. "While Mr.
Gette's resignation was in fact for purely personal reasons, I
anticipate that there will be questions about the current quarter
and Mentor's prospects for the year. Let me say that we are
confident that we will achieve record sales and earnings for the
year.
"As for the current quarter which ends September 30, we expect to
release operating results on October 23. At this time it
appears that both revenues and earnings for the quarter will be
relatively flat compared with the prior year."
Mentor Corporation is a diverse medical products company serving
a number of medical specialties including plastic and
reconstructive surgery, urology, and clinical and consumer
healthcare. This release contains, in addition to historical
information, forward-looking statements. Such statements are
based on management's current expectations and are subject to a
number of uncertainties and risks that could cause actual results
to differ materially from those described in the forward-looking
statements. Factors that may cause such a difference include,
but are not limited to, those described in the Company's Annual
Report on Form 10-K for the fiscal year ended March 31, 2000.
